AU:BIT Stock Latest News
Company AnnouncementsBiotron Boosts Cash Reserves with Additional A$208,463 Tax Refund1w ago
Company AnnouncementsBiotron Releases 2026 Annual Report and Sets AGM Date1w ago
Company AnnouncementsBiotron bolsters board with veteran biotech executive Michael Thurn1w ago
Company AnnouncementsBiotron appoints seasoned healthcare executive Glenn Gilbert as CEO to drive next growth phase2w ago
Company AnnouncementsBiotron CEO Dr Michelle Miller Resigns After 24 Years of Service1M ago
Company AnnouncementsBiotron Switches Share Registry Provider to Automic1M ago
Company AnnouncementsBiotron Outlines Governance and Diversity Framework for FY20262M ago- Company AnnouncementsBiotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty2M ago
Company AnnouncementsBiotron Advances Hepatitis B Candidate BIT-HBV001 Toward Human Trials After Strong Preclinical Data2M ago
Company AnnouncementsBiotron Updates Market on Directors’ Shareholding Changes3M ago
Company AnnouncementsBiotron Seeks ASX Quotation for 83 Million New Shares3M agoCompany AnnouncementsBiotron Clears First SedRx Milestone After EMA Feedback on Regulatory Pathway3M ago
Company AnnouncementsBiotron Secures R&D Tax Rebate to Support Antiviral Drug Development5M ago- Company AnnouncementsBiotron Advances SedRx Anaesthetic Program and Expands Hepatitis Portfolio6M ago
- Company AnnouncementsBiotron Announces Leadership Transition as Long-Term Chairman Retires6M ago
Company AnnouncementsBiotron Strengthens Board With Appointment of Veteran Life Sciences Executive7M ago
Company AnnouncementsBiotron Cautions Investors on Risks in Forward-Looking Statements7M agoCompany AnnouncementsBiotron Expands Hepatitis B Drug Potential and Advances Sedarex Integration7M ago
Company AnnouncementsBiotron Posts Wider Half-Year Loss Amid Zero Revenue and Raised Asset Backing8M ago